The US intends to approve the BioNTech and Pfizer vaccine for coronavirus for use among 12- to 15-year-olds in the coming days, according to legal stakeholders.
Pharmaceutical companies apply for a permit from Start vaccinating young people Last month tests revealed that the infection was 100% effective in preventing symptomatic infections in the group.
Two people close to the program said they expect the Food and Drug Administration to provide green light next week, an idea that could help bring the US closer to the “military” and make it necessary to reopen schools regularly in the autumn.
The FDA and Pfizer declined to comment.
BioNTech / Pfizer vaccine, formerly approved for those aged 16 and over last year, they have been given 131m time, according to a study by the US Centers for Disease Control and Prevention. This has enabled the U.S. to vaccinate more than 50 percent of adults with a single dose, making it one of the largest Covid-19 companies in the world.
Vaccination has helped reduce the number of cases and deaths in the US in recent weeks. According to recent statistics published by the Financial Times, the country reports 50,000 cases and 700 deaths a day – almost the same as the prices met in October last year.
Scientists have said that to reach their livestock – while enough people have antibodies that the virus can no longer spread – however, the US needs to vaccinate more than half of the population. It can be difficult only after children have been vaccinated.
In March, Pfizer also reported the results of phase 3 clinical trials among 12-15 year olds, which showed good results than those aged 16-25. Of the 2,260 young people who took part in the case, 18 were diagnosed with Covid-19 – all in a placebo group.
The FDA, which approves all drugs in the US, must not approve the new Pfizer vaccine for use for less than 16 years, avoiding the need for temporary consultation with foreign experts.
However, the CDC, which provides advice to health professionals, consulted with a team of scientists before submitting their views. The group has been told to wait for a 12- to 15-year-old vaccination workshop with the Pfizer jab next week, according to an expert.
Anthony Fauci, director of the US National Institutes for Allergy and Infectious Diseases, had previously said he hoped high school children would be vaccinated by the end of the year, as well as younger children next year.